Literature DB >> 8632441

Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.

H Ohmoto1, K Nakamura, T Inoue, N Kondo, Y Inoue, K Yoshino, H Kondo, H Ishida, M Kiso, A Hasegawa.   

Abstract

As part of our studies of selectin blockers, we prepared 1-deoxy-3'-O-sulfo LeX analogs (1-3), 1-deoxy-3'-O-phosphono LeX analogs (4), and 1-deoxy sLeX analogs (5-7), and examined their inhibitory activities against natural ligand (sLeX) binding to E-selectin, P-selectin, and L-selectin. The 1-deoxy sLeX 5 was up to 20 times more potent an inhibitor than the sLeX tetrasaccharide toward P- and L-selectin binding. This indicates that the modification of the 1 or 2 position of sLeX is useful in the design of a more potent selectin blocker.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632441     DOI: 10.1021/jm9506478

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis.

Authors:  A Ikegami-Kuzuhara; T Yoshinaka; H Ohmoto; Y Inoue; T Saito
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Role of selectins on IgE-mediated skin reaction.

Authors:  Y Wada; A Kuzuhara; M Hanamura; R Kida; T Yoshinaka; T Saito
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Selectins-The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules-A Review.

Authors:  Igor Tvaroška; Chandrabose Selvaraj; Jaroslav Koča
Journal:  Molecules       Date:  2020-06-19       Impact factor: 4.411

Review 4.  Selectin antagonists : therapeutic potential in asthma and COPD.

Authors:  Suzanne J Romano
Journal:  Treat Respir Med       Date:  2005
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.